bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2023.10.29.564617

MtbEis protein: A new player in stringent response of Mycobacterium tuberculosis

Singh, N.·Basra, V.·Sharma, C.
View original source ↗Export metadata ↓

Abstract

The stringent response in bacteria is an important defense mechanism in which hyperphosphorylated forms of guanosine, also known as molecular alarmones, are synthesized by RelA/SpoT Homolog (RSH) proteins. Rel protein in Mycobacterium tuberculosis (RelMtb) also regulates expression of persistence or virulence associated genes. Loss of RelMtb leads to higher expression of few of the virulence and cell wall remodeling factors in addition to upregulating many secreted antigens and proteins. The Enhanced Intracellular Survival (MtbEis) protein is one of the upregulated virulence factors. Based on this information, the precise role of MtbEis, a GNAT family acetyltransferase, in the stringent response in M. tuberculosis was explored. To begin with, MtbEis has been confirmed to enhance the guanosine pentaphosphate (pppGpp) synthesis activity of RelMtb by acetylating RelMtb at K513. Next, the MtbEis gene was knocked out in Mtb. The deletion of MtbEis resulted in a compromised survival accompanied by elevated levels of rRNAs under starvation conditions. Furthermore, the reduced expression of RelMtb and subsequent decrease in pppGpp synthesis was also observed in Mtb{Delta}Eis cells. Complementation of Mtb{Delta}Eis with full length MtbEis restored the expression of RelMtb, rRNAs, pppGpp levels and survival of M. tuberculosis. However, MtbEis lacking acetyltransferase domain ({Delta}AT) failed to restore this, confirming the role of MtbEis mediated acetylation in regulating stringent response. In sum, our findings not only report the unexplored role of MtbEis in the starvation survival but also the acetylation of RelMtb as a novel mechanistic aspect of stringent response in M. tuberculosis. In addition, this being the first post translational modification (PTM) report on any of the bacterial Rel proteins opens up the field for the discovery of new PTMs of Rel proteins. Author SummaryStringent Response is essential for bacterial survival and pathogenesis under stress conditions. The bifunctional RelMtb enzyme is the key player of stringent response in M. tuberculosis catalyzing the synthesis of pppGpp from ATP and GTP under nutrient deprived conditions. Under stringent conditions, the tight regulation of transcriptional and translational processes aids the intracellular survival of Mtb. Amongst the translational regulations, the post-translational modification (PTM) is one of the most efficient mechanisms regulating the functions of enzymes. None of the PTMs of Rel proteins is known so far. Here, we have not only identified the acetylation of RelMtb by MtbEis but also dissected the consequences of this modification in regulation of stringent response. MtbEis is a known virulence factor belonging to GNAT family acetyltransferase that is upregulated upon stringent response activation in Mtb. The MtbEis regulates expression of rRNAs and RelMtb, synthesis of pppGpp and Mtb survival by acetylating RelMtb under starvation conditions. The regulation of stringent response by MtbEis mediated acetylation of RelMtb have unravelled the novel function of MtbEis in adapting Mtb to existing environmental challenges associated with nutrient deficit state. HighlightsO_LINone of the PTMs of Rel proteins is known so far C_LIO_LIMtbEis interacts with RelMtb and acetylates RelMtb at K513 C_LIO_LIThe acetyltransferase domain of MtbEis regulates rRNAs and RelMtb expression, pppGpp synthesis and Mtb survival under starved conditions C_LIO_LIMtbEis helps Mtb in adapting to nutrient deficit state C_LI

Explore related subjects

microbiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Singh, N., Basra, V., Sharma, C.. 2023-10-30. MtbEis protein: A new player in stringent response of Mycobacterium tuberculosis. https://doi.org/10.1101/2023.10.29.564617

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗
bioRxiv2026

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗
bioRxiv2026

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗